Kewaunee Scientific Files 8-K on Financials
Ticker: KEQU · Form: 8-K · Filed: Sep 10, 2025 · CIK: 55529
| Field | Detail |
|---|---|
| Company | Kewaunee Scientific CORP /De/ (KEQU) |
| Form Type | 8-K |
| Filed Date | Sep 10, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $2.50 |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, results-of-operations
Related Tickers: KEQU
TL;DR
KEQU dropped an 8-K detailing financials - check it for the latest numbers.
AI Summary
Kewaunee Scientific Corporation filed an 8-K on September 10, 2025, to report on its results of operations and financial condition, and to file financial statements and exhibits. The filing details the company's financial performance and provides supporting documentation.
Why It Matters
This filing provides investors with crucial updates on Kewaunee Scientific's financial health and operational results, impacting investment decisions.
Risk Assessment
Risk Level: low — This is a routine financial filing and does not indicate any immediate or significant risks.
Key Players & Entities
- Kewaunee Scientific Corporation (company) — Registrant
- Delaware (jurisdiction) — State of incorporation
- Statesville, NC (location) — Principal executive offices
FAQ
What specific financial statements are included in this 8-K filing?
The filing indicates that financial statements and exhibits are being provided, but the specific details of which statements are included are not detailed in the provided text.
What is the fiscal year end for Kewaunee Scientific Corporation?
The fiscal year end for Kewaunee Scientific Corporation is April 30.
When was Kewaunee Scientific Corporation incorporated?
Kewaunee Scientific Corporation was incorporated in Delaware.
What is the primary business of Kewaunee Scientific Corp?
Kewaunee Scientific Corp is in the business of Laboratory Apparatus & Furniture, with SIC code 3821.
What is the accession number for this 8-K filing?
The accession number for this 8-K filing is 0000055529-25-000033.
Filing Stats: 534 words · 2 min read · ~2 pages · Grade level 12.6 · Accepted 2025-09-10 16:14:06
Key Financial Figures
- $2.50 — ange on which registered Common Stock, $2.50 par value KEQU The Nasdaq Global Marke
Filing Documents
- kequ-20250910.htm (8-K) — 30KB
- prfy26q1earningsrelease.htm (EX-99.1) — 184KB
- logo_stackedxdark.jpg (GRAPHIC) — 280KB
- 0000055529-25-000033.txt ( ) — 712KB
- kequ-20250910.xsd (EX-101.SCH) — 2KB
- kequ-20250910_lab.xml (EX-101.LAB) — 21KB
- kequ-20250910_pre.xml (EX-101.PRE) — 12KB
- kequ-20250910_htm.xml (XML) — 3KB
02 Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition On September 10, 2025, Kewaunee Scientific Corporation issued a press release announcing its financial results for the first quarter of fiscal year 2026. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press Release of Kewaunee Scientific Corporation dated Septe mber 1 0 , 2025. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) In accordance with General Instruction B.2 of Form 8-K, the information in this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. KEWAUNEE SCIENTIFIC CORPORATION (Registrant) Date: September 10, 2025 By /s/ Donald T. Gardner III Donald T. Gardner III Vice President, Finance Chief Financial Officer